Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Return on Sales (2024 - 2025)

Compass Therapeutics' Return on Sales history spans 2 years, with the latest figure at 0.78% for Q2 2025.

  • On a quarterly basis, Return on Sales fell 63.0% to 0.78% in Q2 2025 year-over-year; TTM through Jun 2025 was 0.78%, a 23.0% decrease, with the full-year FY2024 number at 0.67%, changed N/A from a year prior.
  • Return on Sales hit 0.78% in Q2 2025 for Compass Therapeutics, down from 0.62% in the prior quarter.
  • Over the last five years, Return on Sales for CMPX hit a ceiling of 0.15% in Q2 2024 and a floor of 0.78% in Q2 2025.